BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chellapandi P, Saranya S. Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery. Med Chem Res 2020;29:1777-91. [PMID: 32837137 DOI: 10.1007/s00044-020-02610-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Adebiyi MO, Obagbuwa IC. Homology Modeling and Binding Site Analysis of SARS-CoV-2 (COVID-19) Main Protease 3D Structure. Advanced Bioinspiration Methods for Healthcare Standards, Policies, and Reform 2022. [DOI: 10.4018/978-1-6684-5656-9.ch004] [Reference Citation Analysis]
2 Kairov U, Amanzhanova A, Karabayev D, Rakhimova S, Aitkulova A, Samatkyzy D, Kalendar R, Kozhamkulov U, Molkenov A, Gabdulkayum A, Sarbassov D, Akilzhanova A. A high scale SARS-CoV-2 profiling by its whole-genome sequencing using Oxford Nanopore Technology in Kazakhstan. Front Genet 2022;13:906318. [DOI: 10.3389/fgene.2022.906318] [Reference Citation Analysis]
3 Ansari WA, Ahamad T, Khan MA, Khan ZA, Khan MF. Exploration of Luteolin as Potential Anti-COVID-19 Agent: Molecular Docking, Molecular Dynamic Simulation, ADMET and DFT Analysis. LDDD 2022;19:741-756. [DOI: 10.2174/1570180819666211222151725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Saravanan KA, Panigrahi M, Kumar H, Rajawat D, Nayak SS, Bhushan B, Dutt T. Role of genomics in combating COVID-19 pandemic. Gene 2022;823:146387. [PMID: 35248659 DOI: 10.1016/j.gene.2022.146387] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
5 Sepehri B, Kohnehpoushi M, Ghavami R. High predictive QSAR models for predicting the SARS coronavirus main protease inhibition activity of ketone-based covalent inhibitors. J IRAN CHEM SOC 2022;19:1865-76. [DOI: 10.1007/s13738-021-02426-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Najafabadi ZY, Fanuel S, Falak R, Kaboli S, Kardar GA. The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing. Mol Biotechnol 2023;65:146-61. [PMID: 35091986 DOI: 10.1007/s12033-021-00431-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Harigua-Souiai E, Heinhane MM, Abdelkrim YZ, Souiai O, Abdeljaoued-Tej I, Guizani I. Deep Learning Algorithms Achieved Satisfactory Predictions When Trained on a Novel Collection of Anticoronavirus Molecules. Front Genet 2021;12:744170. [PMID: 34912370 DOI: 10.3389/fgene.2021.744170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bhattacharya M, Chatterjee S, Sharma AR, Agoramoorthy G, Chakraborty C. D614G mutation and SARS-CoV-2: impact on S-protein structure, function, infectivity, and immunity. Appl Microbiol Biotechnol 2021. [PMID: 34755213 DOI: 10.1007/s00253-021-11676-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
9 Sahoo A, Fuloria S, Swain SS, Panda SK, Sekar M, Subramaniyan V, Panda M, Jena AK, Sathasivam KV, Fuloria NK. Potential of Marine Terpenoids against SARS-CoV-2: An In Silico Drug Development Approach. Biomedicines 2021;9:1505. [PMID: 34829734 DOI: 10.3390/biomedicines9111505] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ogunyemi OM, Gyebi GA, Ibrahim IM, Olaiya CO, Ocheje JO, Fabusiwa MM, Adebayo JO. Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening. RSC Adv 2021;11:33380-98. [PMID: 35497510 DOI: 10.1039/d1ra05976a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
11 Muhammed Y, Yusuf Nadabo A, Pius M, Sani B, Usman J, Anka Garba N, Mohammed Sani J, Opeyemi Olayanju B, Zeal Bala S, Garba Abdullahi M, Sambo M. SARS-CoV-2 spike protein and RNA dependent RNA polymerase as targets for drug and vaccine development: A review. Biosaf Health 2021;3:249-63. [PMID: 34396086 DOI: 10.1016/j.bsheal.2021.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
12 Chen W, Wang Z, Wang Y, Li Y. Natural Bioactive Molecules as Potential Agents Against SARS-CoV-2. Front Pharmacol 2021;12:702472. [PMID: 34483904 DOI: 10.3389/fphar.2021.702472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Cheng YW, Chao TL, Li CL, Wang SH, Kao HC, Tsai YM, Wang HY, Hsieh CL, Lin YY, Chen PJ, Chang SY, Yeh SH. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage. mBio 2021;12:e0058721. [PMID: 34311586 DOI: 10.1128/mBio.00587-21] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
14 Lucchetta M, Pellegrini M. Drug Repositioning by Merging Active Subnetworks Validated in Cancer and COVID-19.. [DOI: 10.1101/2021.05.13.21257140] [Reference Citation Analysis]
15 Md Nayeem S, Sohail EM, Srihari NV, Indira P, Srinivasa Reddy M. Target SARS-CoV-2: theoretical exploration on clinical suitability of certain drugs. J Biomol Struct Dyn 2022;40:8905-12. [PMID: 33988066 DOI: 10.1080/07391102.2021.1924262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Prathiviraj R, Saranya S, Bharathi M, Chellapandi P. A hijack mechanism of Indian SARS-CoV-2 isolates for relapsing contemporary antiviral therapeutics. Comput Biol Med 2021;132:104315. [PMID: 33705994 DOI: 10.1016/j.compbiomed.2021.104315] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Kumar V, Parate S, Yoon S, Lee G, Lee KW. Computational Simulations Identified Marine-Derived Natural Bioactive Compounds as Replication Inhibitors of SARS-CoV-2. Front Microbiol 2021;12:647295. [PMID: 33967984 DOI: 10.3389/fmicb.2021.647295] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
18 Siddiqa MA, Rao DS, Suvarna G, Chennamachetty VK, Verma MK, Rao MVR. In-Silico Drug Designing of Spike Receptor with Its ACE2 Receptor and Nsp10/Nsp16 MTase Complex Against SARS-CoV-2. Int J Pept Res Ther 2021;:1-8. [PMID: 33746660 DOI: 10.1007/s10989-021-10196-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Manelfi C, Gossen J, Gervasoni S, Talarico C, Albani S, Philipp BJ, Musiani F, Vistoli G, Rossetti G, Beccari AR, Pedretti A. Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease. Molecules 2021;26:797. [PMID: 33557115 DOI: 10.3390/molecules26040797] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
20 Islam MT, Alam ARU, Sakib N, Hasan MS, Chakrovarty T, Tawyabur M, Islam OK, Al-Emran HM, Jahid MIK, Anwar Hossain M. A rapid and cost-effective multiplex ARMS-PCR method for the simultaneous genotyping of the circulating SARS-CoV-2 phylogenetic clades. J Med Virol 2021;93:2962-70. [PMID: 33491822 DOI: 10.1002/jmv.26818] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
21 Cheng Y, Chao T, Li C, Wang S, Kao H, Tsai Y, Wang H, Hsieh C, Chen P, Chang S, Yeh S. D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Viral Transmission via Enhanced Furin-mediated Spike Cleavage.. [DOI: 10.1101/2021.01.27.428541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kaur G, Mukherjee S, Jaiswal S. Bioinformatic Application in COVID-19. Integrated Omics Approaches to Infectious Diseases 2021. [DOI: 10.1007/978-981-16-0691-5_6] [Reference Citation Analysis]
23 Arora S, Lohiya G, Moharir K, Shah S, Yende S. Identification of Potential Flavonoid Inhibitors of the SARS-CoV-2 Main Protease 6YNQ: A Molecular Docking Study. Digital Chinese Medicine 2020;3:239-48. [DOI: 10.1016/j.dcmed.2020.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
24 Islam MT, Alam ASMRU, Sakib N, Hasan MS, Chakrovarty T, Tawyabur M, Islam OK, Al-emran HM, Jahid IK, Hossain MA. A rapid and cost-effective multiplex ARMS-PCR method for the simultaneous genotyping of the circulating SARS-CoV-2 phylogenetic clades.. [DOI: 10.1101/2020.10.08.20209692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]